These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6458922)

  • 1. Diurnal variation in airflow obstruction in chronic bronchitis.
    Dawkins KD; Muers MF
    Thorax; 1981 Aug; 36(8):618-21. PubMed ID: 6458922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of the variability of peak flow rates in chronic bronchitis.
    Ramsdale EH; Morris MM; Hargreave FE
    Thorax; 1986 Oct; 41(10):771-6. PubMed ID: 3538479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
    Sly PD; Landau LI; Olinsky A
    Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.
    van Schayck CP; Folgering H; Harbers H; Maas KL; van Weel C
    Thorax; 1991 May; 46(5):355-9. PubMed ID: 1829865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal variation of peak expiratory flow rate in asthmatic children.
    Sly PD; Hibbert ME; Landau LI
    Pediatr Pulmonol; 1986; 2(3):141-6. PubMed ID: 3737275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of variation in airflow obstruction and risk of death in clinically stable asthma.
    Bohadana AB; Teculescu DB
    Braz J Med Biol Res; 1985; 18(2):157-62. PubMed ID: 3830282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ipratropium bromide in bronchial asthma.
    Taskar V; Mirchandani L; Mahashur AA; Sharma RR; Kolhatkar VP
    J Postgrad Med; 1992; 38(3):124-6. PubMed ID: 1303412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bronchodilators on diurnal rhythms in airway obstruction.
    Connolly CK
    Br J Dis Chest; 1981 Apr; 75(2):197-203. PubMed ID: 7196770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between changes in diurnal variation of expiratory flows, lung volumes and respiratory symptoms after acute asthma.
    Boulet LP; Milot J; Turcotte H
    Respir Med; 1991 Nov; 85(6):487-93. PubMed ID: 1775675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhalation of fenoterol and ipratropium bromide in long-term therapy of chronic reversible airway obstruction.
    Barnabè R; Pirrelli M; Rossi M
    Respiration; 1986; 50 Suppl 2():232-5. PubMed ID: 2951812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate.
    Hetzel MR; Clark TJ
    Thorax; 1980 Oct; 35(10):732-8. PubMed ID: 7466721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal variation in peak expiratory flow rate among grain elevator workers.
    Revsbech P; Andersen G
    Br J Ind Med; 1989 Aug; 46(8):566-9. PubMed ID: 2775676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
    Curzon PG; Martin MA; Cooke NJ; Muers MF
    Thorax; 1983 Aug; 38(8):601-4. PubMed ID: 6225214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation.
    Gomm SA; Keaney NP; Hunt LP; Allen SC; Stretton TB
    Thorax; 1983 Apr; 38(4):297-301. PubMed ID: 6223402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial.
    Guleria R; Behera D; Jindal SK
    J Assoc Physicians India; 1991 Sep; 39(9):680-2. PubMed ID: 1839993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose response study of oxitropium bromide in chronic bronchitis.
    Peel ET; Anderson G
    Thorax; 1984 Jun; 39(6):453-6. PubMed ID: 6463915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ipratropium bromide (atrovent) inhalation in chronic bronchitis.
    Kashyap S; Jindal SK; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):137-40. PubMed ID: 2943673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.